Charged nutritive proteins and methods
Charged nutritive proteins are provided. In some embodiments the nutritive proteins an aqueous solubility of at least 12.5 g/L at pH 7. In some embodiments the nutritive proteins an aqueous solubility of at least 50 g/L at pH 7. In some embodiments the nutritive proteins an aqueous solubility of at least 100 g/L at pH 7. In some embodiments the nutritive proteins comprise at least one of a level of a) a ratio of branch chain amino acid residues to total amino acid residues present in the nutritive protein equal to or greater than the ratio of branch chain amino acid residues to total amino acid residues present in a benchmark protein; b) a ratio of leucine residues to total amino acid residues present in the nutritive protein equal to or greater than the ratio of leucine residues to total amino acid residues present in a benchmark protein; and c) a ratio of essential amino acid residues to total amino acid residues present in the nutritive protein equal to or greater than the ratio of essential amino acid residues to total amino acid residues present in a benchmark protein. Also provided are nucleic acids encoding the proteins, recombinant microorganisms that make the proteins, methods of making the proteins using recombinant microorganisms, compositions that comprise the proteins, and methods of using the proteins, among other things.
1. A nutritive composition comprising a recombinant nutritive protein comprising a polypeptide sequence that is at least 90% homologous to the polypeptide sequence shown in SEQ ID NO:486 and an excipient, wherein the recombinant nutritive protein is present in an amount of at least about 1 g.
2. The nutritive composition of claim 1 , wherein the recombinant nutritive protein is produced by a heterologous microorganism.
3. The nutritive composition of claim 1 , wherein the excipient is selected from the group consisting of: a buffering agent, a preservative, a stabilizer, a binder, a compaction agent, a lubricant, a dispersion enhancer, a disintegration agent, a flavoring agent, a sweetener, and a coloring agent.
4. The nutritive composition of claim 1 , wherein the recombinant nutritive protein consists of a polypeptide sequence that is at least 90% homologous to the polypeptide sequence set forth in SEQ ID NO:486.
5. The nutritive composition of claim 2 , wherein the heterologous microorganism is selected from the group consisting of Escherichia coli, Bacillus subtilis, Bacillus megaterium, Streptomyces coelicolor, Aspergillus niger, Aspergillus nidulans, Aspergillus oryzae, Trichoderma reesei, Saccharomyces cerevisiae, Pichia pastoris , and Pichia stipitis.
6. The nutritive composition of claim 5 , wherein the heterologous microorganism is selected from the group consisting of Escherichia coli, Bacillus subtilis, Saccharomyces cerevisiae , and Aspergillus niger.
7. The nutritive composition of claim 6 , wherein the heterologous microorganism is Bacillus subtilis.
8. The nutritive composition of claim 1 , wherein the nutritive composition is a liquid solution, slurry, suspension, gel, paste, powder, or solid.
9. The nutritive composition of claim 8 , wherein the nutritive composition is a liquid solution.
10. The nutritive composition of claim 1 , wherein the nutritive composition is formulated for oral delivery.
11. The nutritive composition of claim 1 , wherein the nutritive protein is present in an amount selected from 1 g to 5 g, from 2 g to 10 g, from 5 g to 15 g, from 10 g to 20 g, from 15 g to 25 g, from 20 g to 40 g, from 25 to 50 g, or from 30 to 60 g.
12. The nutritive composition of claim 11 , wherein the nutritive protein is present in an amount selected from 15 g to 25 g, from 25 to 50 g, or from 30 to 60 g.
13. The nutritive composition of claim 1 , wherein the nutritive protein is present in an amount of at least 2 g, 3 g, 4 g, 5 g, 6 g, 7 g, 8 g, 9 g, 10 g, 15 g, 20 g, 25 g, 30 g, 35 g, 40 g, 45 g, 50 g, 55 g, 60 g, 65 g, 70 g, 75 g, 80 g, 85 g, 90 g, 95 g, or 100 g.
14. The nutritive composition of claim 13 , wherein the nutritive protein is present in an amount of at least 15 g.
15. The nutritive composition of claim 1 , wherein the polypeptide sequence has an aqueous solubility at pH 7 of at least 50 g/L.
16. The nutritive composition of claim 15 , wherein the polypeptide sequence has an aqueous solubility at pH 7 of at least 100 g/L.
17. The nutritive composition of claim 1 , wherein the polypeptide sequence has a simulated gastric digestion half-life of less than 30 minutes.
18. The nutritive composition of claim 17 , wherein the polypeptide sequence has a simulated gastric digestion half-life of less than 10 minutes.
19. The nutritive composition of claim 18 , wherein the polypeptide sequence has a simulated gastric digestion half-life of less than 2 minutes.
20. The nutritive composition of claim 17 , wherein the polypeptide sequence is completely digested in 30 minutes in simulated gastric fluid.
21. The nutritive composition of claim 1 , wherein the composition comprises least one supplemental mineral or mineral source.
22. The nutritive composition of claim 21 , wherein the supplemental mineral or mineral source is calcium.
23. The nutritive composition of claim 1 , wherein the polypeptide sequence, when present at a concentration of 12.5 mg/mL at pH 7, does not form insoluble aggregates in aqueous solution at 95 degrees Celsius.
24. The nutritive composition of claim 1 , wherein the excipient is about 50% or less, about 45% or less, about 40% or less, about 35% or less, about 30% or less, about 25% or less, about 20% or less, about 15% or less, about 10% or less, about 5% or less, about 2% or less, or about 1% or less of the total weight of the amino acids in the composition.
25. The nutritive composition of claim 1 , wherein the polypeptide sequence has an aqueous solubility at pH 7 of at least 50 g/L; a simulated gastric digestion half-life of less than 10 minutes; wherein the polypeptide sequence, when present at a concentration of 12.5 mg/mL at pH 7, does not form insoluble aggregates in aqueous solution at 95 degrees Celsius.
26. The nutritive composition of claim 25 , wherein the polypeptide sequence is at least 95% homologous to the polypeptide sequence shown in SEQ ID NO:486; and wherein the polypeptide sequence has a simulated gastric digestion half-life of less than 2 minutes.
27. The nutritive composition of claim 25 , wherein the recombinant nutritive protein is present in an amount of at least 15 g to 25 g, 25 to 50 g, or 30 to 60 g, and wherein the nutritive composition is a liquid solution.
28. The nutritive composition of claim 27 , wherein the composition comprises calcium.
29. The nutritive composition of claim 3 , wherein the excipient is selected from the group consisting of: a buffering agent, a preservative, a stabilizer, a dispersion enhancer, a flavoring agent, a sweetener, and a coloring agent.
30. A method for treating sarcopenia, cachexia, or frailty comprising orally administering to a human subject the nutritive composition of claim 28 .
31. A method of maintaining or increasing at least one of muscle mass, muscle strength, and muscle functional performance in a subject, the method comprising orally administering to a human subject the nutritive composition of claim 28 .
32. A method for treating sarcopenia, cachexia, or frailty comprising administering to a human subject on at least a daily basis for at least 1 day at least one dose of the nutritive composition of claim 1 , wherein the nutritive protein is present in an amount selected from 1 g to 5 g, from 2 g to 10 g, from 5 g to 15 g, from 10 g to 20 g, from 15 g to 25 g, from 20 g to 40 g, from 25 to 50 g, or from 30 to 60 g.
33. The method of claim 32 , wherein the nutritive protein accounts for at least 10% of the subject's protein intake of 1.5 g/kg of body weight per day.
34. The method of claim 32 , wherein the nutritive composition is orally consumed by the human subject concurrently with at least one pharmaceutical or biologic drug product.
35. A method for achieving a desirable body mass index, comprising administering to a human subject on at least a daily basis for at least 1 day at least one dose of the nutritive composition of claim 1 , wherein the nutritive protein is present in an amount selected from 1 g to 5 g, from 2 g to 10 g, from 5 g to 15 g, from 10 g to 20 g, from 15 g to 25 g, from 20 g to 40 g, from 25 to 50 g, or from 30 to 60 g.
36. A method of maintaining or increasing at least one of muscle mass, muscle strength, and muscle functional performance in a subject, the method comprising providing to the subject a sufficient amount of the nutritive composition of claim 1 .
37. The method of claim 35 , wherein the nutritive composition is consumed by the subject in an amount effective to induce satiety.
38. The method of claim 32 or claim 36 , wherein the nutritive composition is consumed by the subject in coordination with performance of exercise.
39. The method of claim 32 or claim 36 , wherein the nutritive composition is consumed by the subject by an oral or enteral route.
40. The method of claim 39 , wherein the nutritive composition is consumed by the subject by an oral route.
41. The method of claim 32 or claim 36 , wherein the nutritive composition is consumed at a rate of from 0.1 g to 1 g a day, 1 g to 5 g a day, from 2 g to 10 g a day, from 5 g to 15 g a day, from 10 g to 20 g a day, from 15 g to 30 g a day, from 20 g to 40 g a day, from 25 g to 50 g a day, from 40 g to 80 g a day, or from 50 g to 100 g a day.
42. A method for achieving a desirable body mass index, comprising orally administering to a human subject the nutritive composition of claim 27 .